Tyrosine-kinase associated receptors Flashcards
What is a tyrosine kinase associated receptor?
An enzyme coupled receptor where the kinase domain is non-covalently attached to the receptor.
What is the name of the signalling pathway downstream of tyr kinase associated receptors?
The JAK-Stat pathway
Give examples of tyr kinase associated receptors.
Cytokine receptors, TCRs, and TGF-β receptors.
Give examples of signal proteins that activate the JAK-Stat pathway.
Interferons, erythropoeitin and growth hormone.
Why is growth hormone considered a hormone despite acting via the JAK-Stat pathway?
Produced in the pituitary gland and distributed throughout the body. Stimulates the JAK-Stat pathway via the production of IGF1 which goes on to actviate a tyr kinase associated receptor.
What is growth hormone used to treat?
Stunted growth and short stature.
What is the outcome of the JAK-Stat pathway when activated by interferons? When are interferons used as a drug treatment?
Activation of macrophages and increased resistance to viral infection. Used in antiviral therapy, e.g. in hepatitis treatment.
What is the outcome of the JAK-Stat pathway when activated by erythropoeitin?
Differentiation of erythorocyte progenitors to give erythrocytes (RBCs).
Why is erythropoeitin taken by athletes?
To increase RBC production, in order to give them a higher oxygen capacity.
What are cytokines?
Small proteins (15-25kDa) secreted by immune cells that are used to modulate different immune responses.
What are chemokines?
A subset of cytokines that act as chemoattractants - result in the migration of immune cells to a site of infection.
What are hormones?
Small organic molecules, peptides or proteins that are produced by endocrine glands and distributed throughout the body in the bloodstream. Have a wide variety of effects on target cells.
What are growth factors?
Cytokines or hormones that stimulate cell growth, proliferation and differentiation.
What is JAK?
Janus kinase - with two kinase domains, one of which is catalytically active. The second kinase domain negatively regulates the activity of the first kinase domain. Non-covalently associated to the receptor..
What is Stat?
Signal transducer activated by JAK.
Give an overview of the JAK-Stat pathway.
- Cytokine (or hormone) binding results in dimerisation of the tyr kinase associated receptor.
- Dimerisation allows cross phosphorylation of the JAK kinases bound to each receptor monomer.
- Cross phosphorylation is recognised by Stat proteins, via their SH2 domains.
- Phosphorylation of Stat proteins by JAKs.
- Dimerisation of phosphorylated Stat proteins.
- Stat dimer moves into the nucleus and activates transcription of the target gene - with a cytokine responsive element.
Why is the JAK-Stat pathway a faster way to activate gene expression than the Ras-MAPK pathway?
Only has one intermediate - Stat - which goes straight into the nucleus to activate gene transcription. In comparison, the Ras-MAPK pathway has more intermediates and it takes longer for the information to reach the nucleus.
What is the main disadvantage of the JAK-Stat pathway in comparison to the Ras-MAPK pathway?
The Ras-MAPK pathway is more complex (has more intermediates) and can therefore have more complex regulation. There are less levels of regulation in the JAK-Stat pathway.
What did early studies using the growth hormone conclude about tyr kinase associated receptor dimerisation?
Suggested ligand induced dimerisation
Describe the binding sites in a tyr kinase associated receptor.
The receptor is not symmetric and forms a 4 helix bundle - cannot have identical interfaces. One binding site is stronger than the other, this is where the ligand binds. The second binding site is weaker and is how one receptor binds to another receptor.
What is the main function of dimerisation of tyr kinase associated receptors?
Allows cross phosphorylation of the JAKs bound to each receptor molecule.
What do more recent studies of growth hormone receptor dimers?
Suggest that the receptor exists as a constitutive dimer - only parting in the extracellular domain. Ligand binding causes a conformational change in the cytoplasmic region of the receptor - allows pulling apart kinase domains.
Describe the growth hormone receptor in the inactive state.
The pseudokinase domains block the kinase domains - unblocked when pulled apart upon ligand binding.
Describe the use of a co-receptor by a JAK-associated receptor.
There is the JAK-associated signalling receptor and an interleukin - not involved in signal transduction but without it there is no signal output.